FORT LAUDERDALE, Fla., Dec. 08, 2016 -- (Attorney Advertising) Salpeter Gitkin is investigating potential claims on behalf of investors in Universal Health Services, Inc., resulting from a news story issued by BuzzFeed. UHS investors can contact James P. Gitkin at 800.675.4128 or [email protected] for more information.
On December 7, 2016, BuzzFeed published a report on its website detailing its year-long investigation into UHS's business. BuzzFeed's investigation was "…based on interviews with 175 current and former UHS staff, including 18 executives who ran UHS hospitals; more than 120 additional interviews with patients, government investigators, and other experts; and a cache of internal documents.…" The story also said "Current and former employees from at least 10 UHS hospitals in nine states said they were under pressure to fill beds by almost any method – which sometime meant exaggerating people's symptoms or twisting their words to make them seem suicidal – and to hold them until their insurance payments ran out."
On this disclosure, UHS common stock fell $15.01 per share, or nearly 12%, to close at $111.36 per share on December 7, 2016.
Salpeter Gitkin, LLP is a civil litigation and transactional law firm handling cases throughout the United States. Its principal areas of practice include shareholder and consumer class actions, serious personal injury, complex commercial ligation, and real estate litigation and transactions. The firm is currently investigating and litigating various shareholder claims against major corporations. More information on the firm and its lawyers can be found at www.salpetergitkin.com.
CONTACT: Salpeter Gitkin, LLP Attn: James P. Gitkin, Esq. 1 E. Broward Boulevard Suite 1500 Fort Lauderdale, FL 33301 800-675-4128 954-467-8622 [email protected]


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Italy Fines Apple €98.6 Million Over App Store Dominance
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 



